Home Cart Sign in  
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
Chemical Structure| 26046-90-2 Chemical Structure| 26046-90-2

Structure of H-3-(Me-Se)-Ala-OH
CAS No.: 26046-90-2

Chemical Structure| 26046-90-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Se-Methylselenocysteine is a precursor of methyl selenium, exhibiting powerful chemopreventive and antioxidant activities, capable of inhibiting cancer cell proliferation by inducing apoptosis, and demonstrating good oral bioactivity.

Synonyms: Methylselenocysteine; Se-Methylseleno-L-cysteine; SeMCys

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of H-3-(Me-Se)-Ala-OH

CAS No. :26046-90-2
Formula : C4H9NO2Se
M.W : 182.08
SMILES Code : O=C(O)[C@@H](N)C[Se]C
Synonyms :
Methylselenocysteine; Se-Methylseleno-L-cysteine; SeMCys
MDL No. :MFCD00800565
InChI Key :XDSSPSLGNGIIHP-VKHMYHEASA-N
Pubchem ID :147004

Safety of H-3-(Me-Se)-Ala-OH

GHS Pictogram:
Signal Word:Danger
Hazard Statements:H301+H331-H373-H410
Precautionary Statements:P501-P273-P260-P270-P271-P264-P391-P314-P301+P310+P330-P304+P340+P311-P403+P233-P405
Class:6.1
UN#:3283
Packing Group:

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Caenorhabditis elegans (C. elegans) 100 μM 18 h To study the bioavailability, protein incorporation, and modulation of the antioxidant defense system by Se-Methylselenocysteine. Results showed that all tested selenium compounds were bioavailable, but only SeMet persistently accumulated and was non-specifically incorporated into proteins. However, the protection against chemically-induced reactive species formation was independent of the applied selenium compound. Mol Nutr Food Res. 2019 May;63(9):e1801304
HuH-28 (cholangiocarcinoma cell line) 15, 30, 60, 120 μM 72 hours Measure miRNA expression changes, results showed increased miR-122, -199a Pathol Oncol Res. 2020 Oct;26(4):2669-2681
TFK-1 (cholangiocarcinoma cell line) 240, 480, 960 μM 72 hours Measure miRNA expression changes, results showed increased miR-143 Pathol Oncol Res. 2020 Oct;26(4):2669-2681
HLF (hepatocellular carcinoma cell line) 15, 30, 60, 120 μM 72 hours Measure miRNA expression changes, results showed increased miR-122 and decreased miR-199a Pathol Oncol Res. 2020 Oct;26(4):2669-2681
HMEC cells 1500 ng Se/mL 24, 48, 72, and 96 h Evaluate the effects of Se-Methylselenocysteine on the growth of HMEC cells. Results showed that MSC at 1500 ng Se/mL did not significantly inhibit the growth of HMEC cells. Int J Med Sci. 2015 Sep 5;12(9):748-58
MDA-MB-231 cells 1500 ng Se/mL 24, 48, 72, and 96 h Evaluate the effects of Se-Methylselenocysteine on growth inhibition and apoptosis in MDA-MB-231 cells. Results showed that MSC at 1500 ng Se/mL inhibited the growth of MDA-MB-231 cells, but the effect was lower than MSA. Int J Med Sci. 2015 Sep 5;12(9):748-58
MCF-7 cells 1500 ng Se/mL 24, 48, 72, and 96 h Evaluate the effects of Se-Methylselenocysteine on growth inhibition and apoptosis in MCF-7 cells. Results showed that MSC at 1500 ng Se/mL inhibited the growth of MCF-7 cells, but the effect was lower than MSA. Int J Med Sci. 2015 Sep 5;12(9):748-58
HepG2 cells 1.25~20 µg/mL 24 hours Evaluate the effect of MSC on glucose consumption in HepG2 cells, results showed MSC (5 µg/mL) significantly increased glucose consumption Molecules. 2023 Jul 19;28(14):5499

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Nude mice 786.0 renal cell carcinoma xenograft model Oral 10 mg/kg Once daily for 7 days To evaluate the antitumor activity of MSC in the 786.0 renal cell carcinoma xenograft model, results showed that MSC selectively stabilized tumor vasculature and enhanced the efficacy of subsequent treatments Int J Mol Sci. 2018 Oct 29;19(11):3378
Caenorhabditis elegans (C. elegans) Wildtype and txnrd-1 deletion mutants Hatch incubation 100 μM Single dose, 18 hours To evaluate the protective effects of Se-Methylselenocysteine against oxidative stress and its modulation of the antioxidant defense system. Results showed that Se-Methylselenocysteine protected wildtype C. elegans from chemically-induced reactive oxygen and nitrogen species (RONS) formation, but no protective effect was observed in txnrd-1 deletion mutants. Mol Nutr Food Res. 2019 May;63(9):e1801304
C57BL/6J mice High-fat diet and streptozotocin-induced type 2 diabetes model Oral 6.5 or 13 µg/kg MSC Once daily for four weeks Evaluate the effect of TAC/MSC on blood glucose and lipid metabolism in type 2 diabetic mice, results showed TAC/MSC significantly improved hyperglycemia and lipid metabolism disorder Molecules. 2023 Jul 19;28(14):5499
Sprague-Dawley rats DEN-induced hepatocellular carcinoma rat model Oral 0.3 mg/kg, 1 mg/kg, 3 mg/kg 5 times per week for 6 consecutive weeks MSC treatment significantly alleviated liver injury and nuclear lesions, improved liver function, decreased CD34 expression and NO/NOS levels, and suppressed VEGF expression. Med Sci Monit. 2021 Aug 4;27:e929255

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

5.49mL

1.10mL

0.55mL

27.46mL

5.49mL

2.75mL

54.92mL

10.98mL

5.49mL

Dissolving Methods
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories